Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 36 | 2024 | 264 | 15.930 |
Why?
|
| Asthma | 47 | 2025 | 983 | 12.630 |
Why?
|
| Nebulizers and Vaporizers | 20 | 2024 | 57 | 6.970 |
Why?
|
| Health Literacy | 12 | 2022 | 73 | 5.980 |
Why?
|
| Patient Readmission | 13 | 2024 | 353 | 5.750 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 364 | 4.740 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.450 |
Why?
|
| Hospitalization | 21 | 2024 | 880 | 4.270 |
Why?
|
| Inpatients | 16 | 2024 | 311 | 3.960 |
Why?
|
| Anti-Asthmatic Agents | 10 | 2025 | 78 | 3.290 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 21 | 2.790 |
Why?
|
| Administration, Inhalation | 19 | 2025 | 192 | 2.460 |
Why?
|
| Humans | 119 | 2025 | 89613 | 1.810 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.780 |
Why?
|
| Telemedicine | 6 | 2024 | 189 | 1.780 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.500 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 2646 | 1.460 |
Why?
|
| Quality of Health Care | 5 | 2024 | 386 | 1.220 |
Why?
|
| Child | 25 | 2023 | 7216 | 1.210 |
Why?
|
| Patient Discharge | 4 | 2023 | 323 | 1.080 |
Why?
|
| Self-Management | 3 | 2024 | 42 | 1.080 |
Why?
|
| Parents | 5 | 2020 | 289 | 1.050 |
Why?
|
| Equipment Failure | 2 | 2020 | 120 | 1.030 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 1.020 |
Why?
|
| Female | 54 | 2024 | 46401 | 1.010 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 36 | 1.000 |
Why?
|
| Male | 51 | 2024 | 42488 | 0.980 |
Why?
|
| United States | 21 | 2024 | 7050 | 0.950 |
Why?
|
| Vision Disorders | 2 | 2016 | 75 | 0.940 |
Why?
|
| Health Status Disparities | 2 | 2017 | 191 | 0.930 |
Why?
|
| Minority Groups | 5 | 2019 | 147 | 0.920 |
Why?
|
| Hospitals | 4 | 2023 | 303 | 0.890 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 125 | 0.870 |
Why?
|
| Community Health Workers | 2 | 2022 | 33 | 0.850 |
Why?
|
| Patients | 3 | 2020 | 102 | 0.840 |
Why?
|
| Educational Measurement | 2 | 2016 | 231 | 0.830 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 1725 | 0.820 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 16 | 0.820 |
Why?
|
| Quality of Life | 7 | 2025 | 1673 | 0.800 |
Why?
|
| Length of Stay | 4 | 2024 | 743 | 0.790 |
Why?
|
| Quality Improvement | 4 | 2020 | 455 | 0.780 |
Why?
|
| Mass Screening | 3 | 2017 | 645 | 0.780 |
Why?
|
| Adult | 24 | 2025 | 26704 | 0.760 |
Why?
|
| Patient Participation | 3 | 2024 | 226 | 0.760 |
Why?
|
| Women | 1 | 2021 | 25 | 0.730 |
Why?
|
| Awards and Prizes | 1 | 2021 | 37 | 0.720 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 624 | 0.720 |
Why?
|
| Research Support as Topic | 1 | 2021 | 85 | 0.710 |
Why?
|
| Drug Misuse | 1 | 2020 | 2 | 0.710 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.710 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 652 | 0.710 |
Why?
|
| Research Personnel | 1 | 2021 | 72 | 0.710 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 524 | 0.700 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1180 | 0.690 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 7 | 0.690 |
Why?
|
| Chicago | 11 | 2024 | 1430 | 0.680 |
Why?
|
| Middle Aged | 25 | 2024 | 26012 | 0.680 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1050 | 0.670 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 538 | 0.660 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 217 | 0.660 |
Why?
|
| Disease Management | 3 | 2020 | 326 | 0.650 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1851 | 0.650 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 172 | 0.630 |
Why?
|
| Natural Language Processing | 1 | 2019 | 38 | 0.630 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2025 | 74 | 0.610 |
Why?
|
| Adolescent | 11 | 2024 | 9305 | 0.600 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 714 | 0.590 |
Why?
|
| Students, Medical | 4 | 2024 | 425 | 0.590 |
Why?
|
| Schools | 2 | 2018 | 76 | 0.590 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2024 | 182 | 0.590 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 743 | 0.580 |
Why?
|
| Social Media | 1 | 2019 | 95 | 0.570 |
Why?
|
| Attitude to Health | 1 | 2018 | 222 | 0.570 |
Why?
|
| Betacoronavirus | 1 | 2020 | 262 | 0.560 |
Why?
|
| Risk Factors | 7 | 2022 | 5517 | 0.550 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.540 |
Why?
|
| Accidental Falls | 1 | 2016 | 48 | 0.530 |
Why?
|
| Health Policy | 5 | 2018 | 188 | 0.530 |
Why?
|
| Delirium | 2 | 2016 | 72 | 0.520 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 24 | 0.520 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2025 | 270 | 0.510 |
Why?
|
| Spirometry | 4 | 2023 | 67 | 0.510 |
Why?
|
| Psychometrics | 2 | 2023 | 330 | 0.510 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 425 | 0.510 |
Why?
|
| Data Collection | 3 | 2013 | 376 | 0.500 |
Why?
|
| Disease Progression | 1 | 2020 | 1463 | 0.500 |
Why?
|
| Patient Care Team | 2 | 2018 | 283 | 0.500 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 305 | 0.490 |
Why?
|
| Patient Advocacy | 1 | 2015 | 53 | 0.480 |
Why?
|
| Pediatrics | 1 | 2019 | 357 | 0.480 |
Why?
|
| Medicare | 3 | 2024 | 426 | 0.470 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2025 | 836 | 0.470 |
Why?
|
| HIV Infections | 1 | 2023 | 846 | 0.470 |
Why?
|
| Prospective Studies | 11 | 2024 | 4309 | 0.460 |
Why?
|
| Trust | 2 | 2016 | 97 | 0.450 |
Why?
|
| Aged | 15 | 2024 | 19158 | 0.450 |
Why?
|
| Heart Failure | 1 | 2023 | 1191 | 0.450 |
Why?
|
| Guideline Adherence | 4 | 2024 | 234 | 0.440 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 63 | 0.430 |
Why?
|
| Logistic Models | 3 | 2022 | 1214 | 0.430 |
Why?
|
| Hospital Medicine | 2 | 2023 | 23 | 0.420 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 108 | 0.420 |
Why?
|
| Internship and Residency | 4 | 2012 | 1060 | 0.420 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9127 | 0.420 |
Why?
|
| Biomedical Research | 3 | 2024 | 402 | 0.410 |
Why?
|
| Formoterol Fumarate | 2 | 2025 | 10 | 0.400 |
Why?
|
| Family | 1 | 2013 | 325 | 0.390 |
Why?
|
| Physicians | 3 | 2020 | 691 | 0.390 |
Why?
|
| Urban Population | 4 | 2018 | 225 | 0.390 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 460 | 0.380 |
Why?
|
| Cognition | 1 | 2015 | 578 | 0.370 |
Why?
|
| Schools, Medical | 4 | 2024 | 136 | 0.370 |
Why?
|
| Child, Preschool | 6 | 2023 | 3756 | 0.370 |
Why?
|
| Aging | 1 | 2015 | 724 | 0.360 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.360 |
Why?
|
| Societies, Medical | 3 | 2024 | 582 | 0.350 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2024 | 54 | 0.340 |
Why?
|
| Cost Savings | 2 | 2022 | 69 | 0.340 |
Why?
|
| Chronic Disease | 3 | 2023 | 952 | 0.340 |
Why?
|
| Self Administration | 3 | 2018 | 72 | 0.340 |
Why?
|
| Feasibility Studies | 4 | 2020 | 782 | 0.330 |
Why?
|
| Self Care | 4 | 2016 | 166 | 0.330 |
Why?
|
| Poverty | 3 | 2019 | 183 | 0.320 |
Why?
|
| Teaching | 1 | 2010 | 147 | 0.320 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 84 | 0.310 |
Why?
|
| Educational Status | 2 | 2023 | 195 | 0.300 |
Why?
|
| Comorbidity | 2 | 2024 | 952 | 0.300 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 53 | 0.290 |
Why?
|
| Equipment Design | 2 | 2021 | 420 | 0.290 |
Why?
|
| Students | 2 | 2018 | 170 | 0.280 |
Why?
|
| Self Concept | 2 | 2019 | 134 | 0.280 |
Why?
|
| Internet | 2 | 2020 | 321 | 0.270 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 592 | 0.270 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 433 | 0.260 |
Why?
|
| Curriculum | 2 | 2024 | 571 | 0.250 |
Why?
|
| Communication Barriers | 2 | 2015 | 30 | 0.250 |
Why?
|
| Qualitative Research | 2 | 2018 | 304 | 0.240 |
Why?
|
| Program Evaluation | 2 | 2020 | 312 | 0.240 |
Why?
|
| Cost Sharing | 1 | 2024 | 17 | 0.240 |
Why?
|
| Checklist | 2 | 2016 | 61 | 0.230 |
Why?
|
| Electronic Health Records | 3 | 2017 | 351 | 0.230 |
Why?
|
| Delphi Technique | 1 | 2024 | 100 | 0.230 |
Why?
|
| Control Groups | 1 | 2023 | 15 | 0.220 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 21 | 0.220 |
Why?
|
| Health Promotion | 2 | 2024 | 165 | 0.220 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.220 |
Why?
|
| Sex Distribution | 2 | 2021 | 171 | 0.210 |
Why?
|
| Medication Adherence | 1 | 2024 | 140 | 0.210 |
Why?
|
| Drug Therapy, Combination | 1 | 2025 | 782 | 0.210 |
Why?
|
| Health Expenditures | 2 | 2024 | 90 | 0.200 |
Why?
|
| Health Equity | 1 | 2024 | 96 | 0.200 |
Why?
|
| Polysomnography | 1 | 2022 | 151 | 0.200 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 153 | 0.200 |
Why?
|
| Young Adult | 4 | 2024 | 6368 | 0.200 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 36 | 0.190 |
Why?
|
| Aftercare | 1 | 2022 | 87 | 0.190 |
Why?
|
| Syndrome | 1 | 2022 | 449 | 0.190 |
Why?
|
| Exercise | 1 | 2024 | 326 | 0.190 |
Why?
|
| Exercise Therapy | 1 | 2021 | 82 | 0.190 |
Why?
|
| Time Factors | 3 | 2020 | 5337 | 0.190 |
Why?
|
| Cross Infection | 2 | 2013 | 149 | 0.190 |
Why?
|
| Feedback | 1 | 2021 | 134 | 0.190 |
Why?
|
| Insurance, Health | 2 | 2020 | 164 | 0.190 |
Why?
|
| Physician's Role | 2 | 2013 | 176 | 0.180 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3659 | 0.180 |
Why?
|
| Focus Groups | 2 | 2018 | 176 | 0.180 |
Why?
|
| Needs Assessment | 2 | 2018 | 161 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 263 | 0.170 |
Why?
|
| Prevalence | 3 | 2024 | 1247 | 0.170 |
Why?
|
| School Nursing | 1 | 2019 | 3 | 0.170 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 125 | 0.170 |
Why?
|
| Primary Health Care | 2 | 2020 | 352 | 0.170 |
Why?
|
| Mentors | 2 | 2023 | 88 | 0.160 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 37 | 0.160 |
Why?
|
| Prescription Fees | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cause of Death | 1 | 2020 | 269 | 0.160 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.160 |
Why?
|
| Research Design | 2 | 2024 | 589 | 0.160 |
Why?
|
| Nurses | 1 | 2018 | 40 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2018 | 41 | 0.150 |
Why?
|
| Disabled Children | 1 | 2018 | 44 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 984 | 0.150 |
Why?
|
| Congresses as Topic | 1 | 2019 | 115 | 0.150 |
Why?
|
| Allergens | 1 | 2019 | 183 | 0.150 |
Why?
|
| Counseling | 2 | 2010 | 166 | 0.150 |
Why?
|
| Awareness | 1 | 2018 | 88 | 0.150 |
Why?
|
| Health Education | 1 | 2018 | 105 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2021 | 2304 | 0.150 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 260 | 0.150 |
Why?
|
| Videoconferencing | 1 | 2017 | 15 | 0.150 |
Why?
|
| Lung | 2 | 2022 | 1273 | 0.140 |
Why?
|
| Inhalation | 1 | 2017 | 31 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 6771 | 0.140 |
Why?
|
| Community Participation | 1 | 2017 | 38 | 0.140 |
Why?
|
| Language | 2 | 2015 | 156 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2763 | 0.140 |
Why?
|
| Videotape Recording | 1 | 2017 | 48 | 0.140 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 209 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2020 | 1498 | 0.130 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 25 | 0.130 |
Why?
|
| Bronchodilator Agents | 3 | 2024 | 66 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 41 | 0.130 |
Why?
|
| Sleep | 2 | 2023 | 455 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 89 | 0.130 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.130 |
Why?
|
| Internal Medicine | 2 | 2010 | 362 | 0.130 |
Why?
|
| Medicaid | 1 | 2019 | 238 | 0.130 |
Why?
|
| Face | 1 | 2016 | 117 | 0.130 |
Why?
|
| Advisory Committees | 1 | 2016 | 90 | 0.130 |
Why?
|
| Motivation | 1 | 2018 | 296 | 0.130 |
Why?
|
| Patient Transfer | 1 | 2016 | 95 | 0.130 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.130 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 34 | 0.130 |
Why?
|
| Acetates | 1 | 2015 | 67 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 59 | 0.130 |
Why?
|
| Translating | 1 | 2015 | 18 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1605 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2024 | 2878 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1076 | 0.130 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.120 |
Why?
|
| Androstadienes | 1 | 2015 | 72 | 0.120 |
Why?
|
| Quinolines | 1 | 2015 | 86 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 421 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 434 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2015 | 69 | 0.120 |
Why?
|
| Acute Disease | 1 | 2017 | 842 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2016 | 71 | 0.120 |
Why?
|
| Registries | 1 | 2019 | 791 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 1073 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 777 | 0.110 |
Why?
|
| Patient Selection | 1 | 2017 | 677 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 220 | 0.110 |
Why?
|
| Software | 1 | 2017 | 667 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 345 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 461 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1132 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 179 | 0.080 |
Why?
|
| Documentation | 2 | 2020 | 103 | 0.070 |
Why?
|
| Muscle Stretching Exercises | 1 | 2024 | 1 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8218 | 0.060 |
Why?
|
| Caregivers | 2 | 2017 | 167 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2024 | 30 | 0.060 |
Why?
|
| Postural Balance | 1 | 2024 | 46 | 0.060 |
Why?
|
| Medication Therapy Management | 1 | 2024 | 16 | 0.060 |
Why?
|
| Medicare Part C | 1 | 2024 | 7 | 0.060 |
Why?
|
| Self Efficacy | 1 | 2024 | 56 | 0.060 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 35 | 0.060 |
Why?
|
| Actigraphy | 1 | 2024 | 59 | 0.060 |
Why?
|
| Walking | 1 | 2024 | 93 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2017 | 870 | 0.060 |
Why?
|
| Staff Development | 1 | 2023 | 27 | 0.050 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 149 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 187 | 0.050 |
Why?
|
| Canada | 1 | 2021 | 208 | 0.050 |
Why?
|
| Sodium | 1 | 2021 | 331 | 0.040 |
Why?
|
| Efficiency | 1 | 2020 | 40 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 629 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 351 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 38 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 193 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 48 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 77 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 613 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 13 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 145 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 57 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 127 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 344 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 162 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 484 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 28 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 19 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 43 | 0.030 |
Why?
|
| Sick Leave | 1 | 2012 | 13 | 0.030 |
Why?
|
| Workplace | 1 | 2012 | 30 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 344 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 397 | 0.020 |
Why?
|
| Attention | 1 | 2016 | 395 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2449 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 252 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1598 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 327 | 0.020 |
Why?
|